| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |